Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor

Clinical trial NCT00793871 · COMPLETED

Trial details

NCT number: NCT00793871
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Start date: 2008-11-01
Primary completion: 2014-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.